PDHA1 and breast carcinoma: Furthermore, the oncoprotein Hepatitis B X-interacting protein (HBXIP) has been found to enhance glucose metabolic reprogramming in breast cancer by inhibiting cytochrome C oxidase (SCO2) and PDHA1 [65].